Dr. Samvel Bardakhchyan, MD, PhD, is the Lead of the Adult Oncology team at
the Yeolyan Hematology and Oncology Center. He is a medical oncologist in the
Adults Solid Tumors Chemotherapy Department since May 2019. Prior to that, he
worked in the chemotherapy department at "Muratsan" hospital complex until 2019.
Dr. Bardakhchyan completed his residency in Oncology at the "Muratsan" hospital
complex of Yerevan State Medical University in 2017, after studying at the
university.
Dr. Bardakhchyan won the ASCO International Development and Education Award
in 2020. He received his PhD degree in 2021 and obtained ESMO accreditation in
medical oncology in 2022. He is adjunct assistant professor in oncology at Yerevan
state medical university since 2022. He is scientific director of Immune oncology
research institute since 05/2022. His main areas of interest are thoracic
malignancies, gastrointestinal malignancies and CNS tumors. He has 18 published
research papers and multiple abstracts, and he regularly participates in oncological
conferences and seminars. Dr. Bardakhchyan is the principal investigator of
IMMONC0008 study “Assessment of the Safety and Efficacy of Balstilimab in
combination with Botensilimab for the Treatment of Non-small cell lung cancer”
(NCT06322108). Dr. Bardakhchyan is a member of several professional
organizations, including the Armenian Association of Hematology and Oncology
(AAHO), the European Society for Medical Oncology (ESMO), the Society of
Hematologic Oncology (SOHO), the American Society of Clinical Oncology (ASCO),
and the Armenian Haematology Association (AHA).
About IMMONC
Immune Oncology Research Institute (IMMONC) is dedicated to advancing research aimed at preventing, treating, and ultimately curing cancer while making these innovations accessible to those who need them. If you're interested in joining our team, please feel free to contact us at [email protected] or at +374-41 310-048.